Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | CHKA | P35790 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | IGF1R | P08069 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | DAO | P14920 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18503375 | 0.95 | CYP1A2 (0.38) | TAAR1CYP1A2CYP2A6CHKAKCNH2 | |
| SCHEMBL20373892 | 0.90 | TAAR1 (0.39) | TAAR1CYP1A2CYP2A6CHKAKCNH2 | |
| SCHEMBL27073675 | 0.85 | P2RX7 (0.36) | TAAR1ACHE | |
| SCHEMBL21182741 | 0.84 | HRH3 (0.31) | TAAR1CYP1A2CYP2A6CHKAHRH3 | |
| SCHEMBL18901756 | 0.83 | TAAR1 (0.39) | TAAR1PTGS1PTGS2DAO | |
| SCHEMBL19887710 | 0.82 | RET (0.37) | TAAR1CYP1A2CYP2A6IDO1ACHE | |
| SCHEMBL19197845 | 0.82 | HRH3 (0.37) | PTGS1PTGS2HRH3 | |
| SCHEMBL19197050 | 0.82 | CYP2A6 (0.36) | TAAR1CYP1A2CYP2A6PTGS1PTGS2 | |
| SCHEMBL18511911 | 0.81 | DAO (0.48) | TAAR1PTGS1PTGS2DAO | |
| SCHEMBL17897369 | 0.81 | SRD5A2 (0.37) | TAAR1CYP1A2CYP2A6IDO1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230287272-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DEVICE | DIC CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | DIC CORPORATION (JP) | 2023-08-29 | — | — | US | disclosed |
| US-11639327-B2 | Polymerizable compound, and liquid crystal composition and liquid crystal display device using the same | DIC CORPORATION (JP) | 2023-05-02 | — | — | US | disclosed |
| US-20200255737-A1 | LIQUID-CRYSTALLINE MEDIUM AND HIGH-FREQUENCY COMPONENTS COMPRISING SAME | MERCK PATENT GMBH (DE) | 2020-08-13 | — | — | US | disclosed |
| US-10711197-B2 | Liquid-crystalline medium and high-frequency components comprising same | MERCK PATENT GMBH (DE) | 2020-07-14 | — | — | US | disclosed |
| US-20180208846-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE INCLUDING THE SAME | DIC CORPORATION (JP) | 2018-07-26 | — | — | US | disclosed |
| US-20180187079-A1 | COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | DIC CORPORATION (JP) | 2018-07-05 | — | — | US | disclosed |
| US-20180105748-A1 | LIQUID-CRYSTALLINE MEDIUM, COMPOUNDS, AND HIGH-FREQUENCY COMPONENTS | MERCK PATENT GMBH (DE) | 2018-04-19 | — | — | US | disclosed |
| US-20170253800-A1 | NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | DIC CORPORATION (JP) | 2017-09-07 | — | — | US | disclosed |
| US-20170218270-A1 | LIQUID-CRYSTAL DISPLAY | DIC CORPORATION (JP) | 2017-08-03 | — | — | US | disclosed |
| US-20170218271-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | DIC CORPORATION (JP) | 2017-08-03 | — | — | US | disclosed |
| US-20170210988-A1 | LIQUID-CRYSTAL DISPLAY ELEMENT | DIC CORPORATION (JP) | 2017-07-27 | — | — | US | disclosed |
| US-20170130129-A1 | LIQUID-CRYSTALLINE MEDIUM AND HIGH-FREQUENCY COMPONENTS COMPRISING SAME | MERCK PATENT GMBH (DE) | 2017-05-11 | — | — | US | disclosed |
| US-7854970-B2 | Liquid-crystalline medium | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2010-12-21 | — | — | US | disclosed |
| US-20100051864-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GESELLSCHAFT (DE) | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | OCIAD2, PKN2, SKP1 | TAAR1 2597/4885CYP1A2 2601/4885CYP2A6 1463/4885 |
| US-11639327-B2 | Polymerizable compound, and liquid crystal composition and liquid crystal display device using the same | SKP1, PKN1, KTN1 | TAAR1 3433/4885CYP1A2 3295/4885CYP2A6 4156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.